Impact of residual renal function and HCV seropositivity on plasma CD40/CD40L system and oxidative status in haemodialysis patients
- 31 December 2010
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 43 (18) , 1393-1398
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis doseNephrology Dialysis Transplantation, 2009
- Elevated circulating levels of soluble CD‐40 ligand in haemodialysis patients with symptomatic coronary heart diseaseNephrology, 2008
- Relative Contribution of Residual Renal Function and Different Measures of Adequacy to Survival in Hemodialysis PatientsJournal of the American Society of Nephrology, 2004
- Coronary Artery Disease in End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2003
- Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of deathNephrology Dialysis Transplantation, 2003
- Cytokines in the Pathogenesis of AtherosclerosisThrombosis and Haemostasis, 2002
- Residual renal function and mortality risk in hemodialysis patientsAmerican Journal of Kidney Diseases, 2001
- AtherosclerosisNature, 2000
- CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cellsNature, 1998
- CD40 and Its Ligand1996